The pharmacological properties of melitracen (N 7001) and litracen (N 7049).
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002749:Chlorprothixene / Q000494:pharmacology; D004562:Electrocardiography; D008297:Male; D051379:Mice; D009541:Nictitating Membrane / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013747:Tetrabenazine / Q000037:antagonists & inhibitors
D000873:Anthracenes; D000928:Antidepressive Agents; D010276:Parasympatholytics; D000639:Amitriptyline; D012110:Reserpine; D002749:Chlorprothixene; D013747:Tetrabenazine